The Effect of Low, Moderate, and High Doses of Rosuvastatin on Lipoprotein(A) Levels in Hyperlipidemic Patients with Impaired Fasting Glucose: A Post-Hoc Analysis [Turk Kardiyol Dern Ars]
The Effect of Low, Moderate, and High Doses of Rosuvastatin on Lipoprotein(A) Levels in Hyperlipidemic Patients with Impaired Fasting Glucose: A Post-Hoc Analysis
Aris P. Agouridis1, Theodosios D. Filippatos2, Christina Kostara3, Vasilis Tsimihodimos4, Michalis S. Kostapanos51Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece; School of Medicine, European University Cyprus, Nicosia, Cyprus; Department of Internal Medicine, German Medical Institute, Limassol, Cyprus 2Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece; Department of Internal Medicine, School of Medicine, University of Crete, Heraklion, Greece 3Laboratory of Clinical Chemistry, Faculty of Medicine, University of Ioannina, Ioannina, Greece 4Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece 5Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece; Lipid Clinic, Department of General Medicine, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom
Corresponding Author: Aris P. Agouridis Manuscript Language: English